Literature DB >> 21176937

The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.

Gunjan Choudhary1, Lee Ratner.   

Abstract

Human T-cell leukemia virus type 1 (HTLV-1) basic leucine zipper factor (HBZ) is transcribed from the antisense genomic DNA strand and functions differently in its RNA and protein forms. To distinguish between the roles of hbz mRNA and HBZ protein, we generated mutants in a proviral clone that specifically disrupt the hbz gene product. A proviral clone with a splice acceptor mutation that disrupts expression of the predominant hbz mRNA resulted in lower levels of tax mRNA. Heterologous hbz expression restored Tax activity in cells expressing this mutant clone. In contrast, proviral mutants that disrupt HBZ protein did not affect levels of tax mRNA. Expression of hbz resulted in lower levels of p30(II) mRNA. Mutation of p30(II) overcame the effects of the splice acceptor mutation of hbz, and restored tax expression. Thus, there is a complex interplay of viral regulatory proteins controlling levels of HTLV-1 gene expression.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21176937      PMCID: PMC3034254          DOI: 10.1016/j.virol.2010.11.019

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  39 in total

1.  A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions.

Authors:  R Higuchi; B Krummel; R K Saiki
Journal:  Nucleic Acids Res       Date:  1988-08-11       Impact factor: 16.971

2.  The pX protein of HTLV-I is a transcriptional activator of its long terminal repeats.

Authors:  B K Felber; H Paskalis; C Kleinman-Ewing; F Wong-Staal; G N Pavlakis
Journal:  Science       Date:  1985-08-16       Impact factor: 47.728

3.  Human T-cell leukemia virus minus strand transcription in infected T-cells.

Authors:  D Larocca; L A Chao; M H Seto; T K Brunck
Journal:  Biochem Biophys Res Commun       Date:  1989-09-15       Impact factor: 3.575

Review 4.  Critical role of human T-lymphotropic virus type 1 accessory proteins in viral replication and pathogenesis.

Authors:  Björn Albrecht; Michael D Lairmore
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

5.  HTLV-1-encoded p30II is a post-transcriptional negative regulator of viral replication.

Authors:  Christophe Nicot; Miroslav Dundr; Julie M Johnson; Jake R Fullen; Norma Alonzo; Risaku Fukumoto; Gerald L Princler; David Derse; Tom Misteli; Genoveffa Franchini
Journal:  Nat Med       Date:  2004-01-18       Impact factor: 53.440

6.  The HBZ factor of human T-cell leukemia virus type I dimerizes with transcription factors JunB and c-Jun and modulates their transcriptional activity.

Authors:  Jihane Basbous; Charlotte Arpin; Gilles Gaudray; Marc Piechaczyk; Christian Devaux; Jean-Michel Mesnard
Journal:  J Biol Chem       Date:  2003-08-22       Impact factor: 5.157

7.  Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.

Authors:  Y Hinuma; K Nagata; M Hanaoka; M Nakai; T Matsumoto; K I Kinoshita; S Shirakawa; I Miyoshi
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

8.  Human T-cell lymphotropic virus type 1 open reading frame II-encoded p30II is required for in vivo replication: evidence of in vivo reversion.

Authors:  Lee R Silverman; Andrew J Phipps; Andrew Montgomery; Lee Ratner; Michael D Lairmore
Journal:  J Virol       Date:  2004-04       Impact factor: 5.103

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  HTLV-1 Rex is required for viral spread and persistence in vivo but is dispensable for cellular immortalization in vitro.

Authors:  Jianxin Ye; Lee Silverman; Michael D Lairmore; Patrick L Green
Journal:  Blood       Date:  2003-08-07       Impact factor: 22.113

View more
  14 in total

1.  Inhibiting HDACs in a preclinical model of HTLV-1-induced adult T-cell lymphoma.

Authors:  Robert Harrod
Journal:  Leuk Res       Date:  2011-08-24       Impact factor: 3.156

2.  Permissive Sense and Antisense Transcription from the 5' and 3' Long Terminal Repeats of Human T-Cell Leukemia Virus Type 1.

Authors:  Sylvain Laverdure; Nicholas Polakowski; Kimson Hoang; Isabelle Lemasson
Journal:  J Virol       Date:  2016-01-20       Impact factor: 5.103

3.  PA28γ is a novel corepressor of HTLV-1 replication and controls viral latency.

Authors:  Nga Ling Ko; John M Taylor; Marcia Bellon; Xue Tao Bai; Sergey P Shevtsov; Miroslav Dundr; Christophe Nicot
Journal:  Blood       Date:  2012-10-26       Impact factor: 22.113

4.  Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery.

Authors:  Hélène Gazon; Pradeep Singh Chauhan; Florent Porquet; Gabriela Brunsting Hoffmann; Roberto Accolla; Luc Willems
Journal:  Blood Adv       Date:  2020-11-10

5.  HTLV-1 Rex: the courier of viral messages making use of the host vehicle.

Authors:  Kazumi Nakano; Toshiki Watanabe
Journal:  Front Microbiol       Date:  2012-09-06       Impact factor: 5.640

Review 6.  Orf-I and orf-II-encoded proteins in HTLV-1 infection and persistence.

Authors:  Dustin Edwards; Claudio Fenizia; Heather Gold; Maria Fernanda de Castro-Amarante; Cody Buchmann; Cynthia A Pise-Masison; Genoveffa Franchini
Journal:  Viruses       Date:  2011-06-17       Impact factor: 5.048

Review 7.  Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis.

Authors:  Zhaoxia Qu; Gutian Xiao
Journal:  Viruses       Date:  2011-06       Impact factor: 5.048

8.  Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2.

Authors:  Francesca Rende; Ilaria Cavallari; Maria Grazia Romanelli; Erica Diani; Umberto Bertazzoni; Vincenzo Ciminale
Journal:  Leuk Res Treatment       Date:  2011-12-29

9.  Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis.

Authors:  Xue Tao Bai; Christophe Nicot
Journal:  Front Microbiol       Date:  2012-12-11       Impact factor: 5.640

10.  Long Non-Coding RNAs in Infection Biology.

Authors:  Vinod Scaria; Ayesha Pasha
Journal:  Front Genet       Date:  2013-01-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.